Starting today, patients can save up to $1,200/year on Wegovy (as low as $249/month on annual plans). Affordability drives access. At @ro we’re working directly with @novonordisk to make FDA-approved GLP-1s more accessible by cutting out the middlemen. https://t.co/N63sLZXwO7
@Ro’s first Super Bowl ad. Featuring the GOAT, @serenawilliams, and her journey on Ro—from weight loss to steady blood sugar levels to, as Serena says, having “knees like Megan.” Check out our spot. Couldn’t be more proud of the team. Still just the beginning!
The GOAT @serenawilliams sits down with the one and only @Oprah to talk about her health journey on @ro. SW is such an inspiration and hearing her story directly from her hits different.
Check out the full conversation on The Oprah Podcast here: https://t.co/36KLOEpuWv
@ro is collaborating with Amgen—together, we're going to study insurance coverage of GLP-1s. We've helped millions check their insurance and we can leverage these insights to increase access and reduce cost for patients.
Novo Nordisk's Wegovy pill is launching direct-to-consumer with @ro
CEO @ZReitano breaks down what the launch means for patients, his company's partnership with $NVO, and more https://t.co/6Zo1l3z8k8
Today marks a new era—@novonordisk launched the Wegovy pill on @ro. On Day 1, patients nationwide can immediately access the first FDA-approved GLP-1 pill for weight loss at the best cash price on Ro (starting at $149!). From diagnosis to delivery, in one app, without ever leaving their home.
Excited to partner with @ro to share with folks the massive impact GLP1s had on my life.
I lost 40+ lbs
I feel great
I sleep better
My back pain and sciatica went completely away
Please educate yourself on these compounds and find a great partner like https://t.co/vsTT6brfLd if you do choose to try them.
1/ @serenawilliams is our newest ambassador at @Ro. She’s sharing her weight loss story to inspire others. She has more willpower than most people on the planet and is the perfect example that weight is not just a matter of “diet and exercise”.
Affordability = access. By working with Novo Nordisk, starting today through Ro, patients can get their first month of FDA-approved Wegovy® for $199 plus their first month of the Ro Body membership for just $45.
Telehealth platform @Ro inking a deal with $LLY to offer affordable Zepbound vials to patients
CEO @ZReitano breaks down what this tie-up entails and what the future may hold for the company, this integration, and patients:
https://t.co/tlLMmZ6lbf
@EliLillyandCo’s launch of Zepbound single-dose vials at a lower cash price, direct-to-patient was groundbreaking. Now, @Ro is working with Lilly so that patients can access the vials through one seamless, end-to-end experience. https://t.co/QV8RzZohlm
1/ @Ro is empowering patients and providers with world class technology to achieve life-changing outcomes. https://t.co/QyKr3mocl3
➡️ Avg weight loss: 15.8% after 12 months on GLP-1s
➡️ 80% of patients with metabolic risks improved their lab results
Checking GLP-1 drug insurance coverage just got a little easier, thanks to a new tool from @ro.
CEO @ZReitano explains how it works. He also gives his read on the blockbuster obesity drug market.
At the Jefferies Private Internet Conference, @rick Heitzmann, founder of @FirstMarkCap and investor in @Pinterest, @ro, and @DraftKings, describes the transformation of the New York venture capital and his investing strategy.
Watch his full interview: https://t.co/zczMRCmNnl
Have admired Dr. Allison from afar for a long time and it's been an absolute highlight to learn from and get to know him while building @ro. Couldn't be more excited by his joining our advisory board to help millions of patients reach their health goals. https://t.co/IqUtEdaVXu